Natera, Inc. Announces Second Quarter 2018 Earnings Conference Call


SAN CARLOS, Calif., /PRNewswire/ --Natera, Inc., (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its second quarter ended June 30, 2018, after the market close on Aug. 8, 2018. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.


    Event: Natera's Second Quarter 2018   Financial Results ConferenceCall

    Date:          Wednesday, Aug. 8, 2018

    Time:          1:30 p.m. PT (4:30 p.m. ET)

    Live Dial-In:  (877) 823-0171, Domestic
                   (617) 500-6932, International

    Conference ID: 9889052


A webcast replay will be available at

About Natera
Natera is a global leader in cell-free DNA testing. The mission of the company is to transform the diagnosis and management of genetic diseases. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. Follow Natera on LinkedIn and Twitter.

Investor Relations
Mike Brophy, CFO, Natera, 650-249-9090
Barbara Sullivan, Sullivan & Associates, 714-374-6174,

View original content with multimedia:


Company Codes: NASDAQ-NMS:NTRA

Back to news